3 Key Trends Shaping the CDMO Industry in 2024 and Beyond. #cdmo #contractmanufacturing #pharmaceuticals
Plexus Partners’ Post
More Relevant Posts
-
As the biologics contract manufacturing market continues to grow, CDMOs need to embrace cloud-based, digital quality systems in order to position themselves as industry leaders in the era of advanced drug manufacturing. Learn how AX for Pharma can help your business deliver innovative manufacturing services through digital quality control: https://lnkd.in/daqk6p-q
To view or add a comment, sign in
-
-
As the biologics contract manufacturing market continues to grow, CDMOs need to embrace cloud-based, digital quality systems in order to position themselves as industry leaders in the era of advanced drug manufacturing. Learn how AX for Pharma can help your business deliver innovative manufacturing services through digital quality control: https://lnkd.in/daqk6p-q
To view or add a comment, sign in
-
-
As the biologics contract manufacturing market continues to grow, CDMOs need to embrace cloud-based, digital quality systems in order to position themselves as industry leaders in the era of advanced drug manufacturing. Learn how AX for Pharma can help your business deliver innovative manufacturing services through digital quality control: https://lnkd.in/daqk6p-q
To view or add a comment, sign in
-
-
🌱 💊 We are excited to share this insightful article which explores the challenges of eco-friendly contract manufacturing for the pharmaceutical industry, this article covers Supply Chain Resilience and Optimisation, The Cost-Value Conundrum, Reducing Regulatory and Political Risk and many more challenges that face CDMOs & Pharma companies. #Sustainability #cdmo #pharma #greenpharma
To view or add a comment, sign in
-
What does the future of drug manufacturing look like? What can a CDMO do to manage the quickly changing landscape of pharmaceuticals? In this Endpoints News webinar, Alessandro Maselli, CEO of Catalent Pharma Solutions, talks with editor John Carroll about: -- Stability, trust and growth management that come from working with CDMOs -- What’s changing in the CDMO industry (consolidation, innovations, NDAs) -- The effect of “reshoring” from Asia to the US and/or Europe, thanks to the BIOSECURE Act and other factors At Ritedose, we can help you manage growth and deal with the changing CDMO climate! Watch the webinar recording: https://lnkd.in/e7z6BP6u
CDMOs’ critical role in a rapidly evolving biopharma landscape - Endpoints Webinars
webinars.endpts.com
To view or add a comment, sign in
-
The partner you choose for #plasmid manufacturing impacts your timeline, costs, and product quality. As an array of new plasmid providers enter the biopharmaceutical market to meet demand, drug sponsors must navigate varying levels of #manufacturing skill and choose wisely. While speed and affordability are critical factors, experience is tantamount. As you search for the best fit for your plasmid, Ajinomoto Bio-Pharma Services reviews several key factors to consider, including whether to produce good manufacturing practice (GMP)-grade material from the start.
Optimizing Plasmid Production Strategies & Partnerships
outsourcedpharma.com
To view or add a comment, sign in
-
Happy new year 2024! The first ISPE conference this year is ISPE Aseptics 12-13 March in Vienna. Why to attend: High bandwidth in content to cover from top industry keynotes and three concurrent sessions covering 10 tracks, participants can attend in person or virtually, with all attendees having access to the content on demand for 90-days following the conference. - advancements in automation technology: how it is transforming aseptic processing and manufacturing. - challenges in manufacturing for new targeted Small-Batch Therapies, considerations around manufacturing, quality control, quality management and regulatory compliance. - impact of Annex 1 on Manufacturing, how changes to this document are impacting the manufacturing processes - innovations in Facility Design and Delivery: Attendees will have the opportunity to learn about the latest innovations in facility design and delivery, including emerging trends in technologies, manufacturing, and support areas such as laboratories - GMP compliant investment - unique Challenges Associated with Innovative Pharmaceutical Products: The conference will also focus on the challenges associated with biopharmaceutical products and transfer to biosimilars. - sustainability from product design over manufacturing and CO2 footprint control - regulatory panel with regulators from EMA, FDA, Switzerland, Germany, Austria, Australia and WHO
To view or add a comment, sign in
-
CDMOs are indispensable partners for #pharmaceutical companies, providing the essential flexibility and reliability in an era where resettling supply chains is increasingly vital. The global #CDMO market is projected to grow at approximately 7% annually through 2028, offering ripe opportunities for consolidation and expansion. 📈 Notably, Europe, home to 60% of CDMOs, presents a fertile ground for strategic partnerships and investments. 💡 Our latest publication delves into the opportunities within the CDMO landscape, highlighting avenues for substantial growth and strategic advantages: ➡️ https://lnkd.in/dvgMrvzm #RolandBerger
To view or add a comment, sign in
-
By prioritizing sustainability in your CMO selection process, you not only contribute to a greener future but also position your organisation for long-term success. Don't miss out on this opportunity to stay ahead of the curve and start learning here: https://lnkd.in/e7RAtrQs #CMOSelection #Pharma #CMO #CDMO
[Infographic] CMO Selection: Making Sustainability a Top Priority
pharma-iq.com
To view or add a comment, sign in
-
🎓 Continuous Manufacturing (ICHQ13) Strategies for Biopharmaceuticals | Short Online Course | November 14 & 15 | £396 Early Bird Price During this course, you will learn how to implement a continuous process to enhance quality and reduce time and costs. #educolifesciences #onlinetraining #biopharmaceuticaltraining #continuousmanufacturing
To view or add a comment, sign in
-